Cargando…
An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
The Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The virus has rapidly spread in humans, causing the ongoing Coronavirus pandemic. Recent studies have shown that, similarly to SARS-CoV, SARS-CoV-2 utilises th...
Autores principales: | Trezza, Alfonso, Iovinelli, Daniele, Santucci, Annalisa, Prischi, Filippo, Spiga, Ottavia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431416/ https://www.ncbi.nlm.nih.gov/pubmed/32807895 http://dx.doi.org/10.1038/s41598-020-70863-9 |
Ejemplares similares
-
In Silico Multi-Target Approach Revealed Potential Lead Compounds as Scaffold for the Synthesis of Chemical Analogues Targeting SARS-CoV-2
por: Trezza, Alfonso, et al.
Publicado: (2022) -
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease
por: Spiga, Ottavia, et al.
Publicado: (2020) -
Multi-Omics Model Applied to Cancer Genetics
por: Pettini, Francesco, et al.
Publicado: (2021) -
A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization
por: Bongini, Pietro, et al.
Publicado: (2020) -
Tertiary structure prediction of SARS coronavirus helicase
por: Bernini, Andrea, et al.
Publicado: (2006)